Vitamin B12 Test

Your body depends on vitamin B12 (cobalamin) for two things it cannot do without: making DNA and maintaining the protective coating around your nerves. When levels drop, the damage often begins in your nervous system, causing numbness, tingling, memory problems, and difficulty with balance, sometimes months or years before a routine blood count shows anything wrong. By the time anemia appears, the nerve damage may already be difficult to reverse.

What makes B12 unusual among vitamins is that your body cannot produce it at all. You must get it from animal-based foods, fortified products, or supplements. And getting it from food is not as simple as eating it. Your stomach has to produce enough acid to release B12 from food, your stomach lining has to secrete a special carrier protein called intrinsic factor, and your small intestine has to absorb the B12-carrier complex intact. A breakdown at any of these steps can leave you deficient even if your diet is adequate.

What B12 Actually Does in Your Body

B12 serves as a helper molecule (called a cofactor) for two enzymes. The first converts a potentially harmful amino acid called homocysteine into methionine, a building block your cells need for DNA synthesis and a process called methylation, which is how your body switches genes on and off. The second enzyme helps break down certain fats and amino acids inside your cells' energy-producing compartments (mitochondria). When B12 is low, both of these pathways stall, and the byproducts that accumulate, homocysteine and methylmalonic acid, become measurable markers of the problem.

Nerve and Brain Damage

The most consequential effect of B12 deficiency is neurological damage, and it can happen without any changes to your blood cells. Symptoms include tingling and numbness in the hands and feet, difficulty walking, loss of the ability to sense where your limbs are in space, and a specific pattern of spinal cord damage called subacute combined degeneration. The severity of nerve damage tends to be inversely related to the degree of anemia: patients with the worst neurological problems often have relatively mild blood count changes, which is why waiting for anemia to appear before testing B12 is a dangerous strategy.

Cognitive effects are equally concerning. In the Framingham Heart Study, mental function scores declined significantly faster in people with the lowest B12 levels. Among those with low B12 who were also taking folic acid supplements or had high blood folate, cognitive scores dropped by roughly one point per year on a standard screening test, a rate associated with progression toward dementia. A separate 10-year study found that a doubling in the active form of B12 in the blood (holotranscobalamin) was associated with 30% slower cognitive decline.

Heart Disease and Stroke

The relationship between B12 and cardiovascular risk follows a U-shaped pattern: both low and high levels are associated with increased danger. In a large analysis of over 24,000 adults followed for a median of about nine years, low B12 (below roughly 200 pg/mL) was linked to higher all-cause mortality, while high B12 (above roughly 950 pg/mL) was associated with about a 45% higher risk of cardiovascular death.

Among people with type 2 diabetes, this U-shaped pattern was even more pronounced. A study of nearly 5,000 participants found that those in the lowest and highest quartiles of B12 both had significantly higher cardiovascular death rates compared to those in the middle range, with the lowest quartile carrying about a 50% higher risk and the highest quartile carrying a roughly 60% higher risk.

For stroke, a study of over 25,000 adults found that people with the lowest B12 levels had increased risk of cerebrovascular ischemia (reduced blood flow to the brain). When both B12 and folate were low together, the risk of ischemic stroke or transient ischemic attack was about 2.2 times higher than when both were adequate, and this effect held even after accounting for homocysteine, suggesting B12 affects vascular risk through pathways beyond just homocysteine.

Cancer Associations

High B12 levels have a strong and consistent association with cancer, though this likely reflects the disease rather than causing it. In a study of over 757,000 people in UK primary care, those with B12 above 1,000 pmol/L (roughly 1,355 pg/mL) had a one-year cancer incidence rate nearly 5 times higher than those in the normal range. The highest risks were for liver cancer, pancreatic cancer, and blood cancers.

On the other end, low B12 may also carry risk. A study of male smokers followed for up to 17 years found that those with the lowest prediagnostic B12 levels had about a 5.8-fold higher risk of a specific type of stomach cancer (noncardia gastric adenocarcinoma), an association that strengthened when looking only at cancers diagnosed more than 10 years after the blood draw. A Mendelian randomization analysis, which uses genetic variants to infer causation, found that genetically predicted higher B12 concentrations were associated with about a 16% increased risk of colorectal cancer.

Bone Health

B12 status also affects your skeleton. In the Framingham Osteoporosis Study, higher B12 and B6 levels were each associated with lower hip fracture risk in about 1,000 elderly men and women followed for over 15 years. A separate study of nearly 4,800 elderly adults found that those with high homocysteine (above 15 micromoles per liter, a downstream marker of low B12 and folate) had roughly 70% higher hip fracture risk. These associations held after adjusting for bone density, suggesting B12 affects bone quality through pathways beyond just bone mineral content.

Reference Ranges

B12 assays vary significantly between labs, which means the exact cutpoints your lab uses may differ from published thresholds. Always compare your results within the same lab over time. The following tiers, drawn from major clinical guidelines and large population studies, provide a general framework for interpretation.

These tiers are drawn from published research, including thresholds endorsed by the UK National Institute for Health and Care Excellence and the American Academy of Family Physicians. Your lab may use different assays and cutpoints. Compare your results within the same lab over time for the most meaningful trend.

Ethnicity matters here. Studies using the same assay platform found that Black adults have significantly higher B12 concentrations than White or Asian adults across all age groups. In one UK study, the reference interval for Black adults over age 13 was 225 to 1,091 pg/mL, compared to 182 to 693 pg/mL for White and Asian adults. A result that looks elevated in one population may be entirely normal for another.

The Problem with a Single Reading

Serum B12 testing has a well-documented weakness: false negative and false positive rates that can approach 50% when using standard lab cutoffs. Only about 20% of the B12 your blood test measures is bound to the active transport protein (transcobalamin). The remaining 80% rides on haptocorrin, a protein whose function is poorly understood. This means your total serum B12 can look normal while the biologically active fraction is depleted.

The within-person variation for B12 is about 6.7% to 8.6%, which is relatively stable compared to many other biomarkers. But the reference change value, the minimum change needed to be confident a true biological shift has occurred, is 20% to 31%. A single measurement that looks borderline could be at the bottom of your normal range or the top of your deficient range. Two measurements several months apart will tell you far more than one.

The individuality index for B12 is very low (0.22 to 0.36), meaning population-based reference ranges are poor predictors of what is normal for you specifically. Your own trend line is more informative than any single comparison to a population average. Get a baseline, track your trajectory, and pay attention to the direction of change.

Tracking Your Trend

Because a single B12 result can be misleading, and because your personal normal range may be quite different from the population average, serial tracking is where the real clinical value lies. Start with a baseline measurement. If you are making changes (starting supplementation, switching to a plant-based diet, beginning metformin), retest in 3 to 4 months to see whether your level has responded. After that, test at least annually, or every 6 months if you are in a high-risk group.

A downward trend within the normal range is more informative than a single borderline result. If your B12 drops from 500 to 350 pg/mL over 18 months, that 30% decline exceeds the reference change value and signals a real biological shift worth investigating, even though both numbers technically fall within the normal range. By the time you cross the deficiency threshold, the decline may have been underway for years.

When Results Can Be Misleading

The biggest technical confounder for B12 testing is assay interference in people with autoimmune gastritis. Anti-intrinsic factor antibodies, which are present in pernicious anemia, can interact with the lab's B12 assay and produce falsely normal or even falsely elevated readings. If you have known autoimmune gastritis, a normal B12 result does not rule out deficiency. Methylmalonic acid testing is essential in this situation.

Kidney function affects the interpretation of confirmatory tests but not B12 itself. Methylmalonic acid, the most specific follow-up test for B12 deficiency, can be falsely elevated in kidney disease, dehydration, and thyroid disease. If your kidney function is impaired, an elevated MMA does not automatically confirm B12 deficiency.

Fasting status and time of day have minimal impact on B12 results. A large study of nearly 347,000 patients found no clinically meaningful change in B12 with fasting duration, and B12 shows no significant diurnal variation. You do not need to fast or time your blood draw for this test.